Spinodal

SpinodalSpinodal
S

Spinodal

Developing disposable robotic catheters for interventional cardiology with enhanced accuracy and stability.

2021ActiveBoston, United States
Rate

About

Spinodal is pioneering the development of the first disposable robotic catheter designed for interventional cardiology. Their innovative catheter aims to deliver diagnostics and therapeutics to the myocardium with significantly improved accuracy and stability compared to conventional methods, enabling safer and more reproducible access to complex cardiac anatomies.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Spinodal do?

Spinodal is pioneering the development of the first disposable robotic catheter designed for interventional cardiology. Their innovative catheter aims to deliver diagnostics and therapeutics to the myocardium with significantly improved accuracy and stability compared to conventional methods, enabling safer and more reproducible access to complex cardiac anatomies.

How much funding has Spinodal raised?

Spinodal has raised a total of $12M in funding. The most recent round on record is Seed.

Where is Spinodal headquartered?

Spinodal is headquartered in Boston, United States.

When was Spinodal founded?

Spinodal was founded in 2021.

What industry does Spinodal operate in?

Spinodal operates in Robotics, Healthcare, Catheter, Cardiology, MedTech, HealthTech.

What is Spinodal's revenue?

StartupHub estimates Spinodal's annual revenue at $2.7M (range $881K to $4.2M, 30% confidence), based on comparable companies in the sector.

What is Spinodal's valuation?

StartupHub estimates Spinodal's effective valuation at $47.3M (range $30.0M to $72.0M, 10% confidence), based on comparable companies in the sector.